Worldwide healthtech growth: how the UK and Scotland are positioned
Pharmaceutical Technology
OCTOBER 5, 2022
How the UK is positioned for healthtech growth. The UK’s growth has been similar to global trends, with a CAGR of 11.6% in healthtech, while UK deals accounted for more than one-third of Europe’s healthtech M&A in 2021 and 7.5% In terms of deal value, the UK posted $7.4bn (£6.5bn), the second most globally behind the US.
Let's personalize your content